Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Plasmodium apicoplast 50S ribosomal subunit is a key component of the translation machinery located within the apicoplast, a non-photosynthetic plastid essential for the survival of malaria-causing parasites (Wilson et al., 1996). As the apicoplast is of endosymbiotic origin, its 50S subunit is structurally similar to bacterial ribosomes and significantly different from the human 80S cytosolic ribosome, providing a basis for selective toxicity (Dahl and Rosenthal, 2007). This subunit facilitates the synthesis of proteins required for the maintenance of the apicoplast and its metabolic pathways, such as the non-mevalonate pathway for isoprenoid precursor biosynthesis (Botté et al., 2012). Inhibition of this target by antibiotics like clindamycin or azithromycin disrupts these vital processes, leading to parasite death (Goodman et al., 2007). A unique feature of targeting this subunit is the "delayed death" phenomenon, where the immediate progeny of treated parasites appear viable but fail to survive subsequent replication cycles (Dahl and Rosenthal, 2007). Consequently, drugs hitting this target are often used in combination therapies to ensure rapid clearance of the infection while preventing resistance.
Inhibition of protein synthesis by binding to the 23S rRNA of the 50S ribosomal subunit, thereby blocking the peptidyl transferase center or preventing the translocation of the nascent peptide chain (Dahl and Rosenthal, 2007; Goodman et al., 2007).
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Plasmodium apicoplast 50S ribosomal subunit (Apicoplast 50S ribosome).